• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国炎症性肠病的家族聚集性。

Familial occurrence of inflammatory bowel disease in Korea.

作者信息

Park Jong Beom, Yang Suk-Kyun, Byeon Jeong-Sik, Park Eui-Ryun, Moon Gyoo, Myung Seung Jae, Park Won Kap, Yoon Seo Gue, Kim Hyun Shig, Lee Jong Gyun, Kim Jin Ho, Il Min Young, Kim Kwang Yeon

机构信息

Departments of Internal Medicine and Surgery, Song Do Colorectal Hospital, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Korea.

出版信息

Inflamm Bowel Dis. 2006 Dec;12(12):1146-51. doi: 10.1097/01.mib.0000235094.01608.59.

DOI:10.1097/01.mib.0000235094.01608.59
PMID:17119389
Abstract

BACKGROUND

Little information is available about the familial aggregation of inflammatory bowel disease (IBD) in Asian populations. We therefore determined the risk of familial aggregation of IBD among first-degree relatives of patients with ulcerative colitis (UC) or Crohn's disease (CD) in an ethnically distinct Korean population.

METHODS

Familial aggregation of IBD was evaluated in terms of family history, prevalence, lifetime risk, and population relative risk in first-degree relatives of 1440 unrelated patients with UC (n = 1043) or CD (n = 397).

RESULTS

A positive first-degree family history of IBD was observed in 27 probands (1.88%): 21 of 1043 (2.01%) with UC and 6 of 397 (1.51%) with CD. The crude prevalence of IBD in first-degree relatives of probands with IBD was 0.31%. The lifetime risk of IBD was 0.54% in all first-degree relatives of IBD probands, 0.52% in UC probands, and 0.67% in CD probands, with overall lifetime relative risks of 0.12% in parents, 0.79% in siblings, and 1.43% in offspring. The age- and sex-adjusted population relative risk of IBD was 13.8 in first-degree relatives of probands with IBD.

CONCLUSIONS

Although a positive family history, prevalence, and lifetime risk of IBD among first-degree relatives of Korean IBD patients are much lower than among relatives of Western patients, the population relative risk in first-degree relatives is about equal in Koreans and Westerners. This finding indicates that a positive family history is an important risk factor for IBD in Koreans and in Westerners.

摘要

背景

关于亚洲人群炎症性肠病(IBD)的家族聚集性,目前可用信息较少。因此,我们在一个种族独特的韩国人群中,确定了溃疡性结肠炎(UC)或克罗恩病(CD)患者的一级亲属患IBD的家族聚集风险。

方法

通过家族史、患病率、终生风险以及1440例无亲缘关系的UC患者(n = 1043)或CD患者(n = 397)的一级亲属的人群相对风险,评估IBD的家族聚集性。

结果

在27名先证者(1.88%)中观察到IBD的一级家族史阳性:1043例UC患者中有21例(2.01%),397例CD患者中有6例(1.51%)。IBD先证者的一级亲属中IBD的粗患病率为0.31%。IBD先证者的所有一级亲属的终生风险为0.54%,UC先证者为0.52%,CD先证者为0.67%,父母的总体终生相对风险为0.12%,兄弟姐妹为0.79%,后代为1.43%。IBD先证者的一级亲属中,经年龄和性别调整后的IBD人群相对风险为13.8。

结论

尽管韩国IBD患者的一级亲属中IBD的阳性家族史、患病率和终生风险远低于西方患者的亲属,但韩国人和西方人一级亲属中的人群相对风险大致相当。这一发现表明,阳性家族史是韩国人和西方人患IBD的重要风险因素。

相似文献

1
Familial occurrence of inflammatory bowel disease in Korea.韩国炎症性肠病的家族聚集性。
Inflamm Bowel Dis. 2006 Dec;12(12):1146-51. doi: 10.1097/01.mib.0000235094.01608.59.
2
Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011.炎症性肠病的家族风险:一项基于人群的队列研究(1977 - 2011年)
Am J Gastroenterol. 2015 Apr;110(4):564-71. doi: 10.1038/ajg.2015.50. Epub 2015 Mar 24.
3
Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group).意大利北部炎症性肠病的家族聚集性:一项多中心研究。肠道炎症性疾病研究组(IBD研究组)
Gastroenterology. 1992 Aug;103(2):514-9. doi: 10.1016/0016-5085(92)90841-l.
4
Autoimmune diseases in first- and second-degree relatives of patients with inflammatory bowel diseases: a case-control survey in Israel.炎症性肠病患者一级和二级亲属中的自身免疫性疾病:以色列的病例对照研究。
Minerva Med. 2020 Apr;111(2):107-114. doi: 10.23736/S0026-4806.19.06389-4. Epub 2019 Dec 11.
5
[A case of familial Crohn's disease observed in a parent and his offspring].
Korean J Gastroenterol. 2008 Oct;52(4):247-50.
6
Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis.溃疡性结肠炎患者炎症性肠病的家族聚集性。
Intest Res. 2017 Jul;15(3):388-394. doi: 10.5217/ir.2017.15.3.388. Epub 2017 Jun 12.
7
The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.炎症性肠病患者患结直肠癌的风险:一项基于韩国医院的队列研究。
Scand J Gastroenterol. 2015 Feb;50(2):188-96. doi: 10.3109/00365521.2014.989538. Epub 2014 Dec 17.
8
Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Disease.家族遗传史对炎症性肠病临床病程的影响。
J Crohns Colitis. 2016 Sep;10(9):1024-32. doi: 10.1093/ecco-jcc/jjw063. Epub 2016 Mar 1.
9
Familial occurrence of inflammatory bowel disease in celiac disease.乳糜泻患者炎症性肠病的家族聚集性。
Inflamm Bowel Dis. 2003 Sep;9(5):321-3. doi: 10.1097/00054725-200309000-00006.
10
Inflammatory bowel disease. An epidemiological and genetic study.炎症性肠病。一项流行病学与遗传学研究。
Acta Chir Scand Suppl. 1990;559:1-42.

引用本文的文献

1
Changes in clinical features and seasonal variations of Crohn's disease at diagnosis: a 10-year observational study in China.克罗恩病诊断时的临床特征变化及季节性差异:一项在中国进行的10年观察性研究
Front Med (Lausanne). 2024 Nov 6;11:1489699. doi: 10.3389/fmed.2024.1489699. eCollection 2024.
2
Colitis-associated intestinal microbiota regulates brain glycine and host behavior in mice.结肠炎相关的肠道微生物群调节小鼠的大脑甘氨酸和宿主行为。
Sci Rep. 2022 Sep 29;12(1):16345. doi: 10.1038/s41598-022-19219-z.
3
Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study.
儿童期使用抗生素作为克罗恩病的一个风险因素:ENIGMA国际队列研究
JGH Open. 2022 Jun 1;6(6):369-377. doi: 10.1002/jgh3.12755. eCollection 2022 Jun.
4
What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?亚洲炎症性肠病的不同表型有哪些?
Gut Liver. 2022 Sep 15;16(5):676-685. doi: 10.5009/gnl210385. Epub 2022 Feb 11.
5
Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease.家族性炎症性肠病的宿主遗传和肠道微生物特征。
Clin Transl Gastroenterol. 2020 Jul;11(7):e00213. doi: 10.14309/ctg.0000000000000213.
6
Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior.印度炎症性肠病的家族聚集性:患病率、风险及对疾病行为的影响。
Intest Res. 2019 Oct;17(4):486-495. doi: 10.5217/ir.2018.00174. Epub 2019 Aug 6.
7
Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?炎症性肠病的分子谱分析:是否已准备好用于临床决策?
Cells. 2019 Jun 4;8(6):535. doi: 10.3390/cells8060535.
8
Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients.炎症性肠病的遗传学研究——以亚洲患者为重点。
Cells. 2019 May 1;8(5):404. doi: 10.3390/cells8050404.
9
How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective.炎症性肠病在东西方的流行病学差异如何?韩国视角。
Inflamm Intest Dis. 2017 Nov;2(2):95-101. doi: 10.1159/000454712. Epub 2017 Jan 14.
10
Familial and ethnic risk in inflammatory bowel disease.炎症性肠病中的家族和种族风险。
Ann Gastroenterol. 2018 Jan-Feb;31(1):14-23. doi: 10.20524/aog.2017.0208. Epub 2017 Oct 26.